Literature DB >> 11422174

Psoriasis, psoriatic arthropathy and relapsing orbital myositis.

R Ajitsaria1, R Dale, V Ferguson, S Mayou, N Cavanagh.   

Abstract

Orbital myositis is an inflammatory disorder of the orbital muscles causing orbital pain and restriction of eye movements. Although rare in children, it is most frequently seen after orbital trauma or as a post-infectious process. We describe a child with chronic relapsing psoriasis, juvenile psoriatic arthritis and relapsing bilateral orbital myositis.

Entities:  

Mesh:

Year:  2001        PMID: 11422174     DOI: 10.1046/j.1365-2230.2001.00814.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  6 in total

Review 1.  Identifying and Treating Ocular Manifestations in Psoriasis.

Authors:  Mahsaw Motlagh; Christopher Fortenbach; Howard I Maibach; Bobeck S Modjtahedi
Journal:  Am J Clin Dermatol       Date:  2021-11-03       Impact factor: 7.403

Review 2.  Orbital myositis: diagnosis and management.

Authors:  Roberta M S Costa; Oana M Dumitrascu; Lynn K Gordon
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

3.  An unusual case of orbital myositis in a patient with HLA B-27-associated uveitis.

Authors:  Parthopratim Dutta Majumder; Kirthi Koka; Veena Noronha
Journal:  Indian J Ophthalmol       Date:  2020-04       Impact factor: 1.848

Review 4.  Psoriasis and uveitis.

Authors:  Büşra Köse; Dilek Uzlu; Hidayet Erdöl
Journal:  Int Ophthalmol       Date:  2022-01-19       Impact factor: 2.029

Review 5.  Epidemiology of Ocular Manifestations in Autoimmune Disease.

Authors:  Katie Glover; Deepakkumar Mishra; Thakur Raghu Raj Singh
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561

Review 6.  Psoriasis and uveitis: a literature review.

Authors:  Naiara Abreu de Azevedo Fraga; Maria de Fátima Paim de Oliveira; Ivonise Follador; Bruno de Oliveira Rocha; Vitória Regina Rêgo
Journal:  An Bras Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.